Sign Up Today and Learn More About LENZ Therapeutics Stock
Invest in or calculate the value of your shares in LENZ Therapeutics or other pre-IPO companies through EquityZen's platform.
LENZ Therapeutics Stock (LETH)
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
About LENZ Therapeutics Stock
Founded
2013
Headquarters
Del Mar, CA, US
Industries
Health Care
LENZ Therapeutics Press Mentions
Stay in the know about the latest news on LENZ Therapeutics
LENZ Therapeutics to Present at Upcoming Investor Conferences
biospace • May 27, 2025
LENZ Therapeutics to Present at Upcoming Investor Conferences
globenewswire • May 27, 2025
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
globenewswire • May 10, 2025
LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
globenewswire • May 07, 2025
LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference
globenewswire • May 06, 2025
LENZ Therapeutics Management
Leadership team at LENZ Therapeutics
Founder & Senior Scientific Advisor
Gerald Horn
Co-Founder
James McCollum
Join now and verify your accreditation status to gain access to:
- LENZ Therapeutics Current Valuation
- LENZ Therapeutics Stock Price
- LENZ Therapeutics Management
- Available deals in LENZ Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- LENZ Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- LENZ Therapeutics Revenue and Financials
- LENZ Therapeutics Highlights
- LENZ Therapeutics Business Model
- LENZ Therapeutics Risk Factors
- LENZ Therapeutics Research Report from SACRA Research
Trading LENZ Therapeutics Stock
How to invest in LENZ Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like LENZ Therapeutics through EquityZen funds. These investments are made available by existing LENZ Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell LENZ Therapeutics stock?
Shareholders can sell their LENZ Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
